O2Cure

Blood Oxygenators and Respiratory Assist Devices

Health Tech & Life Sciences
Non Active, Jan 2022
Series B Tirat Carmel, Israel Founded 2013
Last updated 2026-06-18
Total raised
$6.6M
Last:
Stage
Series B
Founded
2013
Headcount
5
HQ
Tirat Carmel, Israel
Sector
Health Tech & Life Sciences

About

O2Cure develops long-term blood oxygenators and respiratory assist devices using novel carbon nanotube technology and a unique design that enables efficient blood oxygenation with reduced harmful effect on blood in pumpless setups. O2Cure's technology is suitable for the development of long-term blood oxygenators and respiratory assist devices for use in hospitals, clinics, and at home.

Funding history · 1 round · $6.6M total

Date unknown

Q&A

What is O2Cure's primary business?
O2Cure develops long-term blood oxygenators and respiratory assist devices using novel carbon nanotube technology.
Where is O2Cure headquartered?
O2Cure is headquartered in Tirat Carmel, North District, Israel.
When was O2Cure founded?
O2Cure was founded in May 2013.
What is the current status of O2Cure?
O2Cure is currently inactive, as of January 2022.
What is O2Cure's total funding raised to date?
O2Cure has raised a total of $6.6 million USD.
What is O2Cure's current funding stage?
O2Cure is currently at the Series B funding stage.

Team · 1

Founder · Founder & Executive Chairman

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesMedical DevicesLife Support
Technologies
Materials & SubstancesNanomaterials
Target customers
Healthcare & Life SciencesHealthcareProviders
Business model
B2B2C

Highlights

1 Patents

Tags

clinicsmedical-devicesnanotechnologyhospitalshome-carerespiratorypulmonary
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)